Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hope Rugo Joyce O'Shaughnessy |
| Publication date | December 20, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |